Navigation Links
Aspirin Lowers Stroke Risk in Peripheral Artery Disease
Date:5/12/2009

But findings limited by lack of studies on subject, researchers note

TUESDAY, May 12 (HealthDay News) -- There haven't been enough studies to tell whether aspirin reduces the risk of heart attack and death for people with the blocked leg blood vessel condition called peripheral arterial disease, but it does cut the incidence of stroke, researchers report.

The finding comes from a meta-analysis of the not-too-many studies of aspirin use with peripheral arterial disease (PAD); it appears in the May 13 issue of the Journal of the American Medical Association.

It's not clear why PAD has been a neglected subject, said study co-author Dr. Mori J. Krantz, an associate professor of medicine at the University of Colorado. "PAD is the unloved stepchild of atherosclerosis, in that it has been understudied."

The degree of neglect was evident in numbers cited in the report. Studies of aspirin therapy in other kinds of atherosclerosis have been numerous. But the largest of the 18 studies of PAD cited in the report included just 1,276 people. The total of all the people in those studies was 5,269.

And 15 of those 18 studies were done more than 10 years ago, said Dr. Mary McGrae McDermott, a professor of medicine at the Northwestern University Feinberg School of Medicine and co-author of an accompanying editorial. "How relative they are to the PAD patient today is not clear."

Overall, those studies found a 12 percent reduction in all cardiovascular events among patients receiving aspirin therapy, compared to those who were not -- a number that did not reach statistical significance. There was no significant reduction in the death rate or incidence of heart attacks, but the incidence of nonfatal stroke was 34 percent lower in the aspirin-taking group.

"We found no evidence of harm or increased bleeding risk with aspirin," Krantz said. "We think that aspirin, for the most part, is a good treatment for atherosclerosis."

"The fact that a statistically significant reduction was not found has a lot to do with the fact that the studies were clinically underpowered," McDermott said. "Antiplatelet therapy should be used for atherosclerosis, and aspirin is certainly the cheapest antiplatelet therapy for PAD."

Antiplatelet therapy is directed at platelets, the blood cells that clump together to form clots that block arteries.

A larger study of antiplatelet therapy such as aspirin in PAD is needed to resolve any doubts, Krantz said. And, in fact, such a study is nearing completion, McDermott said. It is being done in Europe, and its leader has said that results should be available by the end of August, McDermott added.

Meanwhile, what are doctors and people with PAD to do? Pretty much what they have been doing, Krantz said.

"What I do for patients with heart disease is use aspirin," Krantz said. "For those with stroke, I use aspirin. For PAD, we vary it -- sometimes aspirin, sometimes Plavix. But even now, evidence for those combinations has not been proven. We don't know the optimum regimen for patients with PAD."

Plavix is a commonly used prescription drug used to prevent clotting.

"We don't think that anyone with PAD should be stopping their aspirin," said study author Dr. Jeffrey S. Berger, a cardiology fellow at the University of Pennsylvania. "But we need more data to show benefit with 100 percent certainty. It is well known that people with PAD need antiplatelet therapy, but it's unclear what the appropriate agent should be. It is a question that all patients need to address with their health-care providers."

More information

Learn all about PAD from the American Heart Association.



SOURCES: Mori J. Krantz, M.D., associate professor, medicine, University of Colorado, Denver; Mary McGrae McDermott, M.D., professor, medicine, Northwestern University Feinberg School of Medicine, Chicago; Jeffrey S. Berger, M.D., cardiology fellow, University of Pennsylvania, Philadelphia; May 13, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Aspirin Linked to Brain Microbleeds
2. Plavix Plus Aspirin Lowers Stroke Risk
3. New Aspirin Test Now Available in Wichita Area
4. Aspirin recommendation underscores need for physicians and patients to discuss benefits and risk
5. U.S. Preventive Services Task Force Encourages Broader Aspirin Use to Prevent Heart Attack and Stroke
6. Experts Revise Guidelines on Daily Aspirin for Heart
7. Aspirin improves survival in women with stable heart disease, according to WHI study
8. Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials?
9. What is the most effective therapy for low-dose aspirin induced peptic ulcer?
10. Long-Term Aspirin Use Seems to Protect Against Colorectal Lesions
11. Human Body May Make Its Own Aspirin
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirin Lowers Stroke Risk in Peripheral Artery Disease
(Date:2/11/2016)... ... February 11, 2016 , ... According to an article published February ... loss dietary supplement, is being recalled due to the discovery that it contains dangerous ... not a single supplement on the market proven to help people safety lose excess ...
(Date:2/11/2016)... , ... February 11, 2016 , ... Registered nurses, licensed ... CEU seminar titled, “Stroke Management: Time to Act, Time to Heal” on Thursday, February ... in Whippany, N.J. The presenter is Vishal Chedda, president of ANSA Consultants, who will ...
(Date:2/11/2016)... (PRWEB) , ... February 12, 2016 , ... The ... is up from 0.416 in 2013. The SJR uses data taken from the Scopus ... account both the number of citations received by the journal over a three year ...
(Date:2/11/2016)... ... 11, 2016 , ... The Chartis Group, a national advisory ... in the “2015/2016 Best in KLAS: Software and Services” report in two categories: ... and insights firm on a global mission to improve healthcare delivery by amplifying ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader ... to announce the promotions of Allison Kelly to executive vice president of the ... vice president of North American capital sales, and Wendy Oseas to vice president ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016 Potrero ... system, is pleased to announce the appointment of George ... San Antonio, TX , WellMed is ... servicing over 200,000 patients and HMO members in ... founding WellMed in 1990 out of his own internal medicine ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
(Date:2/11/2016)...  AfterPill.com is reporting that this week,s Centers for ... women who are at risk of unintended pregnancy impacts ... raises the risks of unprotected sex in particular.  ... to the Guttmacher Institute, there are 43 million women ... who have sex without the intention of becoming pregnant.  ...
Breaking Medicine Technology: